Paul Thompson
@Pthompsn1018
Followers
895
Following
2K
Media
49
Statuses
1K
Chemical biologist, entrepreneur, maple leafs fan
Joined February 2014
We are hiring!!! TWO Assistant Professors in biochemistry (in brain health and neuroscience). Application: usc https://t.co/ak3CMs7QIu. Re-twitting is highly appreciated... 😊 @UofSC_Chem @USC_HROIS @UofSC @USCResearch @Chemjobber #facultychemjobs
uscjobs.sc.edu
2
9
8
Wow. Investors in Padlock Therapeutics sue Bristol Myers Squibb over ‘milestone’ payments The plaintiffs allege the pharma giant reneged on part of an acquisition agreement. @michael_gilman
https://t.co/KlgX3GyLwI
statnews.com
Investors in Padlock Therapeutics have accused Bristol Myers Squibb of reneging on payments of up to $450 million negotiated as part of a 2016 acquisition agreement.
0
1
8
BRIDGE Fund @UMassChan commits $2 million to take faculty research from the bench to the bedside: https://t.co/dpB0iHo72n
@CantorLab @UMassChanMCCB @RTI_UMassChan @Pthompsn1018 @UMassChan_BMB @Marcus_Ruscetti
umassmed.edu
BRIDGE Innovation and Business Development has set aside nearly $2 million in funding for six faculty-led research projects.
0
4
21
#newscience alert! BIG UPDATE! INCREASED PROTEIN CITRULLINATION IN MOUSE MODELS OF ALS ARE ALSO SEEN IN HUMAN ALS BRAIN SAMPLES!!! @lyleostrow @pthompsn1018
https://t.co/eO80t0ULb0
0
1
5
Very happy to be able to share this preprint from a fab collaboration with @MAChristoLab. It's been a long journey to get here but we hope you'll agree with us that it was worth it. Just a preprint at the moment so any thoughts or suggestions very welcome!
We are very happy to share the result of a wonderful collaboration with @lwalport lab, on the development of a new suite of PAD4/PADI4 modulators A cyclic peptide toolkit reveals mechanistic principles of peptidylarginine deiminase IV (PADI4) regulation
0
3
18
Excited to share our latest article published in @plospathogens: https://t.co/jEsu5Ro7hy
#plospathogensauthor #citrullination #PTM #herpes #HSV @unito @UniAvogadro @NoToVir @Pthompsn1018 @VIPLab6
journals.plos.org
Author summary HSV-1 is a common human pathogen that infects approximately 70% of the population for life. After infection, the virus remains dormant in sensory neurons but reactivates periodically,...
3
3
9
Super cool new paper from the Weerapana lab!!! Profiling nuclear cysteine ligandability and effects on nuclear localization using proximity labeling-coupled chemoproteomics: Cell Chemical Biology
0
4
38
Are you interested in graduate school? Then check out all the new research groups and the entire Department of Chemistry and Biochemistry at the University of South Carolina. Grad applications are FREE this year! https://t.co/T0vaijpgHt
0
16
19
intriguing study further linking PAD6 to infertility. New explanation for infertility: eggs lacking a mysterious ‘lattice’
nature.com
Nature - The discovery of a ‘storage locker’ for essential proteins could explain some cases of infertility.
0
0
4
#AtlasRetreat2023 @LifeSciVC’s Year In Review is sobering. Interesting to see small molecules (“smiracles”?) still dominating deal appetite.
2
9
50
🕸️👀 Inhibition of neutrophil extracellular trap formation alleviates vascular dysfunction in type 1 diabetic mice https://t.co/Y9L2nr1Rkb
science.org
Targeting the innate immune system may be a way to prevent diabetic cardiovascular disease-associated complications.
1
9
24
The product of a wonderful 2-day conference on citrullination last year in Nottingham. Please reach out if interested in copies of our manuscripts on #aging and #Staphylococcus aureus #sepsis in this issue
Citrullination is a chemical protein modification, which has gained great interest because it is associated with #autoimmunity, #neurodegeneration and #cancer progression. Read the new #PhilTransB issue, edited by @MAChristoLab, @psharmalab & Xuesen Zhang: https://t.co/mUINxpAfSM
0
3
10
Citrullination is a chemical protein modification, which has gained great interest because it is associated with #autoimmunity, #neurodegeneration and #cancer progression. Read the new #PhilTransB issue, edited by @MAChristoLab, @psharmalab & Xuesen Zhang: https://t.co/mUINxpAfSM
0
5
8
Please RT and tell your biochemistry/molecular biology/chemical biology/neurobiology/neurochemistry postdocs to apply! We will also welcome applications from established investigators who are looking for a new opportunity. ⤵️⤵️⤵️
We are hiring! Come join our award-winning, collegial department located in the heart of SC. We are seeking applicants for tenure-track positions in both biochemistry and polymer chemistry. @Chemjobber #facultychemjobs
https://t.co/qCe0jXcZAZ
0
14
17
4) These studies follow up on our earlier work showing that SARM1 undergoes a phase transition in vivo https://t.co/nlfCDx9qL5
elifesciences.org
The catalytic activity of SARM1, a key promoter of neuronal degeneration, is activated by >2000-fold by a phase transition.
0
0
1
3) The key finding is that upon undergoing a liquid to solid phase transition, NMN agonizes SARM1 activity at concentrations as low as 5 micromolar versus 500 micromolar when in the liquid state. These concentrations of NMN are physiologically relevant.
1
0
2
2) This study led by superstar graduate student Janneke Icso shows that SARM1 undergoes a phase transition that increases its sensitivity to NMN, an known agonist that increases SARM1 activity.
1
0
1
1) Latest from the lab! A phase transition reduces the threshold for nicotinamide mononucleotide-based activation of SARM1, an NAD(P) hydrolase, to physiologically relevant levels - Journal of Biological Chemistry
jbc.org
Axonal degeneration is a hallmark feature of neurodegenerative diseases. Activation of the NAD(P)ase sterile alpha and toll-interleukin receptor motif containing protein 1 (SARM1) is critical for...
1
1
9
cool paper from @doc_jlmeier Comparative Analysis of Drug-like EP300/CREBBP Acetyltransferase Inhibitors | ACS Chemical Biology
pubs.acs.org
The human acetyltransferase paralogues EP300 and CREBBP are master regulators of lysine acetylation whose activity has been implicated in various cancers. In the half-decade since the first drug-like...
0
1
13
#newscience alert! We're working to take the STING out of diseases like #ALS, #lupus, & #SAVI. A new publication from @Pthompsn1018 @FitzgeraldKate describes a promising new #STING inhibitor that could change the game for these diseases. #advancingtogether
umassmed.edu
Dr. Paul Thompson of the Biochemistry & Molecular Biotechnology department at UMass Chan Medical School recently published a newly discovered inhibitor of STING signaling that could be a promising...
1
4
13